MoneyWorks4Me

Abbott India informs about analyst meet

26 Sep 2022 Evaluate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Abbott India has informed that it attached schedule of Investors/Analysts meeting with the Company. There will not be any presentation at the Meeting. Also, no Unpublished Price Sensitive Information pertaining to the Company will be shared during this Meeting. The said intimation is also available on the website of the Company at www.abbott.co.in.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1231.85
Cipla 1325.00
Lupin 1955.80
Zydus Lifesciences 1124.30
View more..